PERCEPTIVE ADVISORS LLC
NEW YORK, NY · CIK 1224962 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2010 · limited liability company
- Assets managed$11.8bn
- Staff49 · 28 in investment roles
- Main clients (by assets)Private funds 99%
- Private funds17 (6 hedge) · $11.7bn gross assets
- Form ADV · 2026-07-13SEC adviser record
- Legal entityPERCEPTIVE ADVISORS LLC (US)
Options: 1 call positions ($24.1m notional), 6 put positions ($197.2m notional) – listed below, not included above.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| PRAXIS PRECISION MEDICINES I PRAX | $681.6m10.58% | Unchanged |
| SPYRE THERAPEUTICS INC SYRE | $383.5m5.95% | Added +536.3k |
| CELCUITY INC CELC | $334.5m5.19% | Added +70.0k |
| ASCENDIS PHARMA A/S ASND | $310.4m4.82% | New |
| RHYTHM PHARMACEUTICALS INC RYTM | $287.2m4.46% | Added +212.5k |
| ROIVANT SCIENCES LTD ROIV | $286.1m4.44% | Reduced -200.0k |
| RELAY THERAPEUTICS INC RLAY | $263.9m4.10% | Added +4.4m |
| TRAVERE THERAPEUTICS INC TVTX | $213.2m3.31% | Reduced -390.0k |
| KARDIGAN INC KARD | $195.6m3.04% | New |
| NUVALENT INC COM | $195.2m3.03% | Unchanged |
| EDGEWISE THERAPEUTICS INC EWTX | $177.7m2.76% | Reduced -50.0k |
| APOGEE THERAPEUTICS INC COM | $173.6m2.70% | Reduced -232.3k |
| AMYLYX PHARMACEUTICALS INC AMLX | $149.7m2.32% | Added +50.0k |
| MEIRAGTX HLDGS PLC MGTX | $145.7m2.26% | Added +460.6k |
| ORUKA THERAPEUTICS INC ORKA | $128.0m1.99% | Reduced -50.4k |
| INHIBRX BIOSCIENCES INC INBX | $123.0m1.91% | Reduced -144.9k |
| PROTAGONIST THERAPEUTICS INC PTGX | $120.4m1.87% | Reduced -249.0k |
| SOLID BIOSCIENCES INC SLDB | $118.9m1.85% | Unchanged |
| ZYMEWORKS INC ZYME | $109.3m1.70% | Added +672.9k |
| TANGO THERAPEUTICS INC TNGX | $105.6m1.64% | Added +2.6m |
| IMMATICS N.V IMTX | $105.2m1.63% | Unchanged |
| NURIX THERAPEUTICS INC NRIX | $104.8m1.63% | Added +609.5k |
| BIOCRYST PHARMACEUTICALS INC BCRX | $103.1m1.60% | Added +2.9m |
| REVOLUTION MEDICINES INC RVMD | $98.8m1.53% | Added +269.0k |
| AVALYN PHARMACEUTICALS INC AVLN | $88.1m1.37% | New |
| DYNE THERAPEUTICS INC DYN | $59.7m0.93% | Reduced -2.0m |
| BIOGEN INC BIIB | $59.7m0.93% | New |
| IMMUNOVANT INC IMVT | $52.3m0.81% | Reduced -240.0k |
| UNITEDHEALTH GROUP INC UNH | $48.5m0.75% | New |
| IONIS PHARMACEUTICALS INC IONS | $44.9m0.70% | Added +62.0k |
| SUTRO BIOPHARMA INC STRO | $43.3m0.67% | Added +589.5k |
| ALTO NEUROSCIENCE INC ANRO | $42.5m0.66% | Reduced -400.0k |
| JAZZ PHARMACEUTICALS PLC JAZZ | $41.0m0.64% | Unchanged |
| CORVUS PHARMACEUTICALS INC CRVS | $39.9m0.62% | Added +375.0k |
| SIONNA THERAPEUTICS INC SION | $39.8m0.62% | Added +246.6k |
| CYTOMX THERAPEUTICS INC CTMX | $39.1m0.61% | Added +340.4k |
| ARTIVION INC AORT | $39.0m0.61% | Added +100.0k |
| X4 PHARMACEUTICALS INC XFOR | $37.0m0.58% | Added +1.2m |
| CORCEPT THERAPEUTICS INC CORT | $34.6m0.54% | Added +348.4k |
| REPLIGEN CORP RGEN | $33.9m0.53% | Reduced -32.3k |
| ANTERIS TECHNOLOGIES GLOBAL AVR | $33.7m0.52% | Unchanged |
| RAPPORT THERAPEUTICS INC RAPP | $32.2m0.50% | Added +99.4k |
| DAMORA THERAPEUTICS INC COM NEW | $31.8m0.49% | Unchanged |
| CHARLES RIV LABS INTL INC CRL | $31.8m0.49% | New |
| AXSOME THERAPEUTICS INC AXSM | $29.0m0.45% | Reduced -31.5k |
| DBV TECHNOLOGIES S A DBVT | $27.1m0.42% | Added +689.0k |
| IRHYTHM TECHNOLOGIES INC IRTC | $26.6m0.41% | Added +118.7k |
| ADAPTIVE BIOTECHNOLOGIES COR ADPT | $26.1m0.41% | Added +1.1m |
| SAB BIOTHERAPEUTICS INC SABS | $25.8m0.40% | Added +195.8k |
| DANAHER CORPORATION DHR | $24.8m0.38% | New |
| TENAX THERAPEUTICS INC TENX | $24.7m0.38% | Added +252.2k |
| NAUTILUS BIOTECHNOLOGY INC NAUT | $21.8m0.34% | Reduced -960.0k |
| ORCHESTRA BIOMED HLDGS INC OBIO | $21.7m0.34% | Unchanged |
| INTUITIVE SURGICAL INC ISRG | $20.6m0.32% | Reduced -33.5k |
| ADLAI NORTYE LTD ANL | $20.6m0.32% | New |
| CONTINEUM THERAPEUTICS INC CTNM | $20.6m0.32% | Unchanged |
| NUVECTIS PHARMA INC NVCT | $18.4m0.29% | New |
| PALISADE BIO INC PALI | $17.6m0.27% | Reduced -503.1k |
| OMADA HEALTH INC OMDA | $17.3m0.27% | Unchanged |
| LEONABIO INC LONA | $17.1m0.27% | Unchanged |
| EVOLUS INC EOLS | $17.1m0.27% | Added +1.2m |
| INVIVYD INC IVVD | $16.1m0.25% | Reduced -2.4m |
| CELCUITY INC CELC 2.75 08.01.31 · principal | $14.6m0.23% | Unchanged |
| MIRUM PHARMACEUTICALS INC MIRM | $13.5m0.21% | New |
| SURROZEN INC SRZN | $13.1m0.20% | Added +274.6k |
| BETA BIONICS INC BBNX | $13.1m0.20% | Reduced -10.0k |
| AXOGEN INC AXGN | $11.4m0.18% | Reduced -450.0k |
| OSCAR HEALTH INC OSCR | $11.4m0.18% | New |
| OCULIS HOLDING AG OCS | $11.2m0.17% | Added +315.0k |
| SEAPORT THERAPEUTICS INC SPTX | $10.9m0.17% | New |
| VIRIDIAN THERAPEUTICS INC VRDN | $10.7m0.17% | Reduced -588.8k |
| BOSTON SCIENTIFIC CORP BSX | $10.7m0.17% | New |
| BILLIONTOONE INC BLLN | $10.4m0.16% | Reduced -5.0k |
| ABIVAX SA ABVX | $9.9m0.15% | Reduced -254.9k |
| NATERA INC NTRA | $9.4m0.15% | New |
| ENGENE THERAPEUTICS INC ENGN | $8.3m0.13% | New |
| RESEARCH ALLIANCE CORP III RACC | $8.0m0.12% | New |
| AGOMAB THERAPEUTICS NV AGMB | $7.8m0.12% | Unchanged |
| CULLINAN THERAPEUTICS INC CGEM | $7.8m0.12% | New |
| UNIQURE NV QURE | $7.7m0.12% | New |
| MOBIA MED INC MOBI | $7.0m0.11% | New |
| ADAGIO MED HLDGS INC ADGM | $6.4m0.10% | Added +10 |
| GUARDANT HEALTH INC GH | $6.2m0.10% | Reduced -258.7k |
| PHATHOM PHARMACEUTICALS INC PHAT | $5.8m0.09% | Reduced -393.0k |
| OUTLOOK THERAPEUTICS INC OTLK | $5.0m0.08% | New |
| COGENT BIOSCIENCES INC COGT | $4.7m0.07% | Unchanged |
| EDESA BIOTECH INC EDSA | $4.6m0.07% | Unchanged |
| AVALO THERAPEUTICS INC AVTX | $4.1m0.06% | Added +80.1k |
| TWIST BIOSCIENCE CORP TWST | $3.8m0.06% | Reduced -113.2k |
| CRESCENT BIOPHARMA INC. CBIO | $3.7m0.06% | Unchanged |
| XERIS BIOPHARMA HOLDINGS INC XERS | $3.7m0.06% | New |
| OUTSET MED INC OM | $3.6m0.06% | Unchanged |
| BIODESIX INC BDSX | $2.5m0.04% | New |
| REVOLUTION MEDICINES INC RVMDW | $2.3m0.04% | Unchanged |
| CONNECT BIOPHARMA HLDGS LTD CNTB | $1.9m0.03% | Unchanged |
| KIORA PHARMACEUTICALS INC KPRX | $1.2m0.02% | New |
| MEDLINE INC MDLN | $1.1m0.02% | Unchanged |
| ADMA BIOLOGICS INC ADMA | $952.2k0.01% | Reduced -353.5k |
| CUMBERLAND PHARMACEUTICALS I CPIX | $628.4k0.01% | Reduced -100.0k |
| EXAGEN INC XGN | $534.3k0.01% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| ASCENDIS PHARMA A/S | $350.3m1.5m shares |
| CENTESSA PHARMACEUTICALS PLC | $208.9m5.3m shares |
| ENGENE HOLDINGS INC | $39.7m5.8m shares |
| DAY ONE BIOPHARMACEUTICALS I | $37.6m1.8m shares |
| BRIGHT MINDS BIOSCIENCES INC DRUG | $27.5m377.5k shares |
| BELITE BIO INC BLTE | $24.2m152.0k shares |
| EVOMMUNE INC EVMN | $10.3m448.4k shares |
| NEUMORA THERAPEUTICS INC. NMRA | $10.0m5.1m shares |
| NEUROCRINE BIOSCIENCES INC NBIX | $8.6m65.0k shares |
| OPUS GENETICS INC IRD | $8.4m1.8m shares |
| INHIBIKASE THERAPEUTICS INC IKT | $3.9m2.3m shares |
| APELLIS PHARMACEUTICALS INC APLS | $3.3m81.0k shares |
| PALATIN TECHNOLOGIES INC PTN | $1.1m61.9k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| MODERNA INC MRNA · Put | $70.0m1.0m shares | Unchanged |
| SPDR SER TR XBI · Put | $47.5m300.0k shares | New |
| EYEPOINT PHARMACEUTICALS INC EYPT · Put | $28.6m2.0m shares | New |
| CAPRICOR THERAPEUTICS INC CAPR · Call | $24.1m1.0m shares | New |
| SELLAS LIFE SCIENCES GROUP I SLS · Put | $22.1m1.5m shares | New |
| NEWAMSTERDAM PHARMA COMPANY NAMS · Put | $16.9m500.0k shares | New |
| CAPRICOR THERAPEUTICS INC CAPR · Put | $12.0m500.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 38.
| Company | Stake |
|---|---|
| ADAGIO MED HLDGS INC ADGM · 13G · filed 2026-05-15 | 55.4%≈ $8.8m |
| LEONABIO INC LONA · 13D · filed 2026-10-26 | 20.0%≈ $17.4m |
| LYRA THERAPEUTICS INC LYRA · 13D · filed 2025-08-14 | 15.6% |
| MEIRAGTX HLDGS PLC MGTX · 13D · filed 2026-04-24 | 12.6%≈ $158.6m |
| SOLID BIOSCIENCES INC SLDB · 13D · filed 2026-08-14 | 11.2%≈ $120.3m |
| PERCEPTIVE CAP SOLUTIONS COR FRNM · 13G · filed 2026-07-23 | 10.1% |
| INHIBRX BIOSCIENCES INC INBX · 13G · filed 2026-08-14 | 10.0%≈ $141.1m |
| ALTO NEUROSCIENCE INC ANRO · 13G · filed 2026-08-14 | 10.0%≈ $110.2m |
| OPUS GENETICS INC IRD · 13G · filed 2026-08-14 | 10.0%≈ $37.6m |
| ENGENE HOLDINGS INC 13G · filed 2026-08-14 | 10.0% |
| KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-08-10 | 10.0%≈ $1.2m |
| ENVVENO MEDICAL CORPORATION 13G · filed 2026-02-17 | 10.0% |
| ORCHESTRA BIOMED HLDGS INC OBIO · 13G · filed 2025-11-14 | 10.0%≈ $24.5m |
| TRINITY BIOTECH PLC 13D · filed 2026-05-04 | 9.9% |
| OUTSET MED INC OM · 13G · filed 2025-02-28 | 9.5% |
| NAUTILUS BIOTECHNOLOGY INC NAUT · 13D · filed 2026-08-14 | 9.1%≈ $21.8m |
| KARDIGAN INC KARD · 13D · filed 2026-10-01 | 8.8%≈ $196.9m |
| QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-10-14 | 8.4%≈ $1.7m |
| RESEARCH ALLIANCE CORP III RACC · 13G · filed 2026-05-28 | 8.2%≈ $8.0m |
| X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 | 8.1%≈ $37.8m |
| SUTRO BIOPHARMA INC STRO · 13G · filed 2026-08-14 | 7.9%≈ $43.3m |
| PALISADE BIO INC PALI · 13G · filed 2026-05-15 | 7.9%≈ $29.5m |
| IMMATICS N.V IMTX · 13D · filed 2026-08-27 | 7.6%≈ $113.5m |
| AMYLYX PHARMACEUTICALS INC AMLX · 13G · filed 2026-05-15 | 7.5%≈ $148.8m |
| SAB BIOTHERAPEUTICS INC SABS · 13G · filed 2026-08-14 | 7.3%≈ $25.8m |
Trades reported as a company insider since 1 Apr 2026
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2026-08-26 | IMMATICS N.V Director · See Footnote | Bought | $7.5m863.1k shares |